Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma Academic Article uri icon

Overview

MeSH Major

  • Fallopian Tube Neoplasms
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Polyglutamic Acid
  • Taxoids

abstract

  • CT-2103 is active in patients with recurrent ovarian cancer. Neurotoxicity in these heavily pretreated patients was more frequent than predicted from phase I trials. Further study to define toxicity and efficacy in patients with less prior therapy is ongoing.

publication date

  • December 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2004.12.043

PubMed ID

  • 15542803

Additional Document Info

start page

  • 4523

end page

  • 31

volume

  • 22

number

  • 22